Milner & Daiichi Sankyo: Precision Drug Delivery

The Milner Therapeutics Institute is pleased to welcome colleagues from the Daiichi Sankyo Research Institute Munich for an afternoon focused on precision drug delivery and opportunities for research collaboration.

The event will provide a unique opportunity to meet members of Daiichi Sankyo's European team and introduce them to research expertise and capabilities from across the Cambridge ecosystem.

Senior Daiichi Sankyo colleagues will present the company's current research focus and priorities for external research collaboration, with scientific topics including:

• Oncology with ADC technology
• Drug delivery technologies for nucleic acids, including LNP platforms for mRNA vaccine delivery
• Modalities of interest across different therapy areas

The afternoon will include presentations from Daiichi Sankyo, a networking session and opportunities for 1:1 meetings with the Daiichi Sankyo team to explore potential areas for partnership and collaboration.

The event is open to academics, clinician scientists and biotechnology companies working in research areas relevant to Daiichi Sankyo.

Places are limited. Registration is free and required to attend.

If you are interested in a 1:1 meeting, please indicate this during registration and provide brief details of the research, technology or potential collaboration you would like to discuss.

For further information and to register for the event